Target Name: CD53
NCBI ID: G963
Review Report on CD53 Target / Biomarker Content of Review Report on CD53 Target / Biomarker
CD53
Other Name(s): CD53 molecule, transcript variant 1 | cell surface antigen | CD53 variant 1 | CD53 glycoprotein | Leukocyte surface antigen CD53 | CD53_HUMAN | Cell surface glycoprotein CD53 | CD53 molecule | TSPAN25 | Tetraspanin-25 | cell surface glycoprotein CD53 | antigen MOX44 identified by monoclonal antibody MRC-OX44 | CD53 antigen | tetraspanin-25 | MOX44 | transmembrane glycoprotein | Leukocyte surface antigen CD53 (isoform 1) | Tspan-25 | CD53 tetraspan antigen | tspan-25

CD53: A Potential Drug Target and Biomarker

Introduction

CD53 is a transcription factor that belongs to the RNA-binding protein family and is mainly expressed in T cells and NK cells of immune cells. CD53 plays an important role in the immune response and is involved in regulating the activity and function of immune cells. In recent years, researchers have conducted in-depth studies on CD53 and found that CD53 may have potential therapeutic value in certain diseases, such as cancer, autoimmune diseases, and neurodegenerative diseases. This article will introduce the structure, function, action targets and potential drug targets of CD53, and discuss the prospects of CD53 in clinical application.

Structure and function of CD53

CD53 is a 43kDa protein consisting of 514 amino acids. Its N-terminus is rich in phenylalanine residues, and its C-terminus is rich in cysteine 鈥嬧?媟esidues. CD53 has RNA-binding activity and can bind to a variety of RNA molecules, including mRNA, rRNA and tRNA. In addition, CD53 also has DNA-binding ability and can bind DNA in the nucleus.

The function of CD53 in immune cells

CD53 plays a variety of important roles in immune cells. In T cells, CD53 is a ligand bound by the T cell receptor (TCR), which is the main domain responsible for recognizing antigens. The combination of CD53 and TCR can initiate the cell cycle of T cells and participate in the proliferation and differentiation of T cells. In NK cells, CD53 is involved in cell activation, differentiation and death. In addition, CD53 also participates in signal transduction of immune cells and regulates the function of immune cells.

CD53 target

CD53 is an important molecule that plays an important role in a variety of diseases. In recent years, researchers have discovered that CD53 is closely related to the occurrence and development of various diseases.

1. Cancer

CD53 is closely related to the onset and development of cancer. Studies have found that the expression level of CD53 is closely related to the prognosis and treatment response of various cancers, such as lung cancer, breast cancer, ovarian cancer, and colon cancer. In addition, CD53 is also related to the evasion of immune surveillance and immune escape of tumor cells.

2. Autoimmune diseases

CD53 also plays an important role in autoimmune diseases. Studies have shown that CD53 is closely related to the occurrence and development of many autoimmune diseases (such as rheumatoid arthritis, autoimmune hepatitis, and autoimmune thyroid diseases). In addition, CD53 may also be involved in the excessive activation of immune cells, leading to the occurrence of autoimmune diseases.

3. Neurodegenerative diseases

Neurodegenerative diseases (such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis) are common diseases that are closely related to the overactivation of the immune system and the death of related neurons. Studies have found that CD53 may play an important role in these diseases and is closely related to the onset and development of the disease.

Potential drug target for CD53

CD53 is an important molecule with high value in drug research. Researchers have found that CD53 can be used as a drug target to treat a variety of diseases.

1. Cancer

CD53 is a potential drug target that can be used to treat various cancers. For example, CD53 inhibitors have been used to treat a variety of cancers, such as lung, breast, and ovarian cancer.

2. Autoimmune diseases

CD53 is also a potential drug target that can be used to treat autoimmune diseases. For example, researchers are exploring the role of CD53 inhibitors in treating rheumatoid arthritis and other autoimmune diseases.

3. Neurodegenerative diseases

CD53 is also a potential drug target for the treatment of neurodegenerative diseases. For example, CD53 inhibitors have been used to treat diseases such as Parkinson's disease and multiple sclerosis.

in conclusion

CD53 is an important molecule that plays an important role in the immune system and nervous system. CD53 is also closely related to the occurrence and development of various diseases. CD53 is a potential drug target that can be used to treat a variety of diseases. Future research will continue to further study the mechanism of action of CD53 and explore its potential in clinical applications.

Protein Name: CD53 Molecule

Functions: Required for efficient formation of myofibers in regenerating muscle at the level of cell fusion. May be involved in growth regulation in hematopoietic cells (By similarity)

The "CD53 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CD53 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CD55 | CD58 | CD59 | CD5L | CD6 | CD63 | CD68 | CD69 | CD7 | CD70 | CD72 | CD74 | CD79A | CD79B | CD8 | CD80 | CD81 | CD81-AS1 | CD82 | CD83 | CD84 | CD86 | CD8A | CD8B | CD8B2 | CD9 | CD93 | CD96 | CD99 | CD99L2 | CD99P1 | CDA | CDADC1 | CDAN1 | CDC123 | CDC14A | CDC14B | CDC14C | CDC16 | CDC20 | CDC20-DT | CDC20B | CDC20P1 | CDC23 | CDC25A | CDC25B | CDC25C | CDC26 | CDC27 | CDC27P2 | CDC34 | CDC37 | CDC37L1 | CDC37P1 | CDC40 | CDC42 | CDC42BPA | CDC42BPB | CDC42BPG | CDC42EP1 | CDC42EP2 | CDC42EP3 | CDC42EP4 | CDC42EP5 | CDC42SE1 | CDC42SE2 | CDC45 | CDC5L | CDC5L complex | CDC6 | CDC7 | CDC73 | CDCA2 | CDCA3 | CDCA4 | CDCA4P3 | CDCA5 | CDCA7 | CDCA7L | CDCA8 | CDCP1 | CDCP2 | CDH1 | CDH10 | CDH11 | CDH12 | CDH13 | CDH13-AS2 | CDH15 | CDH16 | CDH17 | CDH18 | CDH19 | CDH2 | CDH20 | CDH22 | CDH23 | CDH24 | CDH26 | CDH3